Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

New England Journal of Medicine

Volumn 367, Issue 8, 2012, Pages 695-704

  Carlsson, Lena M S ^a   Peltonen, Markku ^a,d   Ahlin, Sofie ^a   Anveden, Åsa ^a   Bouchard, Claude ^e   Carlsson, Björn ^a   Jacobson, Peter ^a   Lönroth, Hans ^a   Maglio, Cristina ^a   Näslund, Ingmar ^c   Pirazzi, Carlo ^a   Romeo, Stefano ^a   Sjöholm, Kajsa ^a   Sjöström, Elisabeth ^a   Wedel, Hans ^b   Svensson, Per Arne ^a   Sjöström, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DATA ANALYSIS; ETHNIC GROUP; FEMALE; GASTRIC BANDING; GASTROPLASTY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; REOPERATION; RISK REDUCTION; SENSITIVITY ANALYSIS; STOMACH BYPASS; SURGICAL MORTALITY; SWEDISH; TREATMENT OUTCOME; WEIGHT CHANGE;

EID: 84865293878     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1112082     Document Type: Article

References (39)

1. Westlund K, Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol: a follow-up of 3.751 men aged 40-49. Scand J Clin Lab Invest Suppl 1972; 127:1-24.
2. Colditz GA, Willett WC, Stampfer MJ, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132:501-13.
3. Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701-10.
4. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214-22.
5. Leibson CL, Williamson DF, Melton LJ III, et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001; 24:1584-9.
6. Burke JP, Williams K, Narayan KM, Leibson C, Haffner SM, Stern MP. A population perspective on diabetes prevention: whom should we target for preventing weight gain? Diabetes Care 2003;26:1999-2004.
7. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
8. de Lauzon-Guillain B, Balkau B, Charles MA, Romieu I, Boutron-Ruault MC, Clavel-Chapelon F. Birth weight, body silhouette over the life course, and incident diabetes in 91,453 middle-aged women from the French Etude Epidemiologique de Femmes de la Mutuelle Generale de l'Education Nationale (E3N) Cohort. Diabetes Care 2010;33:298-303.
9. Naser KA, Gruber A, Thomson GA. The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-7.
10. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
11. Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2005;28:2780-6.
12. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roqué IFM, Richter B, Mauricio D. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev 2008;3:CD003054.
13. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-6 [Erratum, Diabetes Care 2004;27:856.]
14. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
15. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
16. Lindström J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-9.
17. Diabetes Prevention Program Research Group. 10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-86. [Erratum, Lancet 2009;374:2054.]
18. Li G, Zhang P, Wang J, et al. The longterm effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year followup study. Lancet 2008;371:1783-9.
19. Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med 2007;45:348-52.
20. McTigue K, Larson JC, Valoski A, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006;296:79-86.
21. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.
22. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-52.
23. Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009;10:653-62.
24. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65.
25. Wilhelmsen L, Tibblin G, Aurell M, Bjure J, Ekström-Jodal B, Grimby G. Physical activity, physical fitness and risk of myocardial infarction. Adv Cardiol 1976; 18:217-30.
26. Thune I, Njølstad I, Løchen ML, Førde OH. Physical activity improves the metabolic risk profiles in men and women: the Tromsø Study. Arch Intern Med 1998;158: 1633-40. [Erratum, Arch Intern Med 1998;159:17.]
27. Larsson I, Lissner L, Näslund I, Lindroos A. Leisure and occupational physical activity in relation to body mass index in men and women. Scand J Food Nutr 2004;48:165-72.
28. Lindroos AK, Lissner L, Sjöström L. Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects. Eur J Clin Nutr 1993;47:461-81.
29. Executive summary: standards of medical care in diabetes - 2011. Diabetes Care 2011;34:Suppl 1:S4-S10.
30. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999. (Report no. 99.2.)
31. Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. New York: Oxford University Press, 2003.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
33. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28:628-42.
34. Runkel N, Colombo-Benkmann M, Huttl TP, et al. Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis 2011;26:397-404.
35. Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010;251:399-405.
36. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122(3):248.e5-256.e5.
37. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010;61:393-411.
38. Marchetti P, Dotta F, Lauro D, Purrello F. An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment. Regul Pept 2008;146:4-11.
39. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Rouxen-Y gastric bypass surgery for obesity. Obes Surg 2010;20:1245-50.